Abstract
Congenital adrenal hyperplasia (CAH) is an autosomal recessive corticosteroid biosynthesis disorder most commonly associated with 21-hydroxylase deficiency resulting in low cortisol, increased androgens causing virilization in females and salt-wasting disease in both sexes. A quality improvement initiative was undertaken to evaluate care of CAH patients to identify opportunities to align practice with current clinical practice guidelines (CPG).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
